Citadel Advisors
HIMS icon

Citadel Advisors’s Hims & Hers Health HIMS Stock Holding History

Citadel Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.4M Buy
846,936
+152,162
+22% +$4.08M ﹤0.01% 2124
2026
Q1 		$14.4M Sell
694,774
-1,265,136
-65% -$29.9M ﹤0.01% 2733
2025
Q4 		$63.6M Buy
1,959,910
+1,804,139
+1,158% +$77.3M 0.01% 1209
2025
Q3 		$8.84M Sell
155,771
-974,847
-86% -$50M ﹤0.01% 3458
2025
Q2 		$56.4M Buy
1,130,618
+472,208
+72% +$21.3M 0.01% 1150
2025
Q1 		$19.5M Buy
658,410
+510,455
+345% +$19M ﹤0.01% 2070
2024
Q4 		$3.58M Sell
147,955
-1,724,217
-92% -$42.7M ﹤0.01% 4531
2024
Q3 		$34.5M Sell
1,872,172
-310,042
-14% -$5.55M 0.01% 1542
2024
Q2 		$44.1M Buy
2,182,214
+322,026
+17% +$5.36M 0.01% 1252
2024
Q1 		$28.8M Sell
1,860,188
-127,035
-6% -$1.43M 0.01% 1707
2023
Q4 		$17.7M Buy
1,987,223
+900,307
+83% +$6.66M ﹤0.01% 2141
2023
Q3 		$6.84M Sell
1,086,916
-768,254
-41% -$5.71M ﹤0.01% 3193
2023
Q2 		$17.4M Sell
1,855,170
-15,106
-0.8% -$150K ﹤0.01% 2025
2023
Q1 		$18.6M Buy
1,870,276
+429,947
+30% +$3.77M ﹤0.01% 1998
2022
Q4 		$9.23M Buy
1,440,329
+672,859
+88% +$3.83M ﹤0.01% 2949
2022
Q3 		$4.28M Sell
767,470
-48,496
-6% -$292K ﹤0.01% 4133
2022
Q2 		$3.7M Buy
815,966
+274,741
+51% +$1.17M ﹤0.01% 4372
2022
Q1 		$2.88M Sell
541,225
-423,547
-44% -$2.1M ﹤0.01% 5289
2021
Q4 		$6.32M Buy
964,772
+633,099
+191% +$4.58M ﹤0.01% 3884
2021
Q3 		$2.5M Buy
+331,673
New +$2.81M ﹤0.01% 5807
2021
Q2 		– Sell
-75,870
Closed -$902K – 13979
2021
Q1 		$1M Buy
+75,870
New +$1.27M ﹤0.01% 8103

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors's HIMS Position: Q2 2026 in Review

Citadel Advisors increased its Hims & Hers Health (HIMS) stake by 22% in Q2 2026, buying an estimated $4.08M and bringing the position to 846,936 shares worth $29.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2124.

Citadel Advisors first reported a position in HIMS in Q1 2021 and has held it in 21 quarters since. The position peaked at $63.6M in Q4 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Citadel Advisors held 846,936 shares of Hims & Hers Health worth $29.4M as of Q2 2026.
  • Citadel Advisors bought 152,162 Hims & Hers Health shares in Q2 2026, an estimated $4.08M.
  • Hims & Hers Health made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #2124 holding.
  • Citadel Advisors first reported a position in Hims & Hers Health in Q1 2021 and has held it in 21 quarters since.
  • Citadel Advisors's Hims & Hers Health position peaked at $63.6M in Q4 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.